Open AccessEpidermal growth factor receptor inhibitor in advanced basal cell carcinoma
Author(s) -
Amirabadi Amir,
Alami Amirhosein,
Ahanchian Hamid,
Ariaee Nazila,
Moazzen Nasrin
Publication year - 2021
Publication title -
clinical case reports
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4021
Subject(s) - cetuximab , medicine , basal cell carcinoma , epidermal growth factor receptor , chemotherapy , cancer research , oncology , pathology , receptor , basal cell , cancer , colorectal cancer
Cetuximab can be used for the treatment of advanced basal cell carcinoma, especially when the patient cannot tolerate routine chemotherapy. Future studies are needed to confirm it.